mTORC1 shutdown unleashes TFEB to drive triple-negative breast cancer invasion
Developmental Cell · 2025
DOI: 10.1016/j.devcel.2025.03.006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Developmental Cell, 2025. Verfasst von Michalis Gounis und 2 weiteren Autor:innen. Beteiligte Einrichtung: Turku Bioscience Centre, University of Turku and Åbo Akademi University, 20520 Turku, Finland. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Basic Helix-Loop-Helix Leucine Zipper Transcription Factors, TOR Serine-Threonine Kinases, Multiprotein Complexes. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Turku Bioscience Centre, University of Turku and Åbo Akademi University, 20520 Turku, Finland.
- Turku Bioscience Centre, University of Turku and Åbo Akademi University, 20520 Turku, Finland; Department of Life Technologies, University of Turku, 20520 Turku, Finland; InFLAMES Research Flagship, University of Turku,…
Zitieren
APA
Gounis, M., Hamidi, H., & Ivaska, J. (2025). mTORC1 shutdown unleashes TFEB to drive triple-negative breast cancer invasion. Developmental Cell. https://doi.org/10.1016/j.devcel.2025.03.006
Vancouver
Gounis M, Hamidi H, Ivaska J. mTORC1 shutdown unleashes TFEB to drive triple-negative breast cancer invasion. Developmental Cell. 2025. doi:10.1016/j.devcel.2025.03.006
BibTeX
@article{Gounis2025,
author = {Gounis, Michalis and Hamidi, Hellyeh and Ivaska, Johanna},
title = {mTORC1 shutdown unleashes TFEB to drive triple-negative breast cancer invasion},
journal = {Developmental Cell},
year = {2025},
doi = {10.1016/j.devcel.2025.03.006}
}
EUVIMED